Let’s hope the yield sign comes down soon
That would be a huge boost in what they’re doing going forward.
New investors are going to be coming in here, and this Hestia deal is a bright future.
CLX was just an app.
We were all counting on a DA, and then to sell on DA news.
No one here honestly thought CLX was going to be anything huge in the long-term.
But mental illness is virtually the #1 growing sector of the medical field.
Partnering with Hestia and US Stem Cell is huge.
Even only capturing 0.1% of the one trillion dollar market of mental illness worldwide, puts PASO at a billion dollar market cap. That puts the share price here at about $0.80, but realistically could go higher.
First things first, we’ll be seeing silver land soon.